AVEO PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Aveo Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2022 was $245K, a 5.04% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $245K -$13K -5.04% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $200K -$58K -22.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $100K -$158K -61.2% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $151K -$7K -4.43% Dec 31, 2021 10-Q 2022-11-07
Q3 2021 $258K +$100K +63.3% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $258K +$100K +63.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $258K +$100K +63.3% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $158K Dec 31, 2020 10-K 2022-03-14
Q3 2020 $158K Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $158K Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $158K -$54K -25.5% Mar 31, 2020 10-Q 2020-04-30
Q1 2019 $212K +$201K +1827% Mar 31, 2019 10-Q 2019-05-09
Q3 2018 $4K -$14K -77.8% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $7K -$15K -68.2% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $11K -$15K -57.7% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $15K -$15K -50% Dec 31, 2017 10-K 2019-03-14
Q3 2017 $18K -$1.05M -98.3% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $22K -$388K -94.6% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $26K -$98K -79% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $30K +$4K +15.4% Dec 31, 2016 10-K 2018-03-13
Q3 2016 $1.07M +$907K +553% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $410K +$222K +118% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $124K -$89K -41.8% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $26K -$213K -89.1% Dec 31, 2015 10-K 2017-03-22
Q3 2015 $164K +$119K +264% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $188K +$91K +93.8% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $213K -$45K -17.4% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $239K -$51K -17.6% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $45K -$258K -85.1% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $97K -$233K -70.6% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $258K -$109K -29.7% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $290K -$31K -9.66% Dec 31, 2013 10-K 2015-03-06
Q3 2013 $303K -$5K -1.62% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $330K -$26K -7.3% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $367K +$269K +274% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $321K +$200K +165% Dec 31, 2012 10-K 2014-03-13
Q3 2012 $308K +$78K +33.9% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $356K +$126K +54.8% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $98K Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $121K -$335K -73.5% Dec 31, 2011 10-K 2013-03-11
Q3 2011 $230K Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $230K Jun 30, 2011 10-Q 2011-08-09
Q4 2010 $456K Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.